Monitoring of cancer patients undergoing active or passive immunotherapy

被引:19
作者
Salgaller, ML
机构
[1] Immunotherapeuties Division, Northwest Biotherapeutics L.L.C, Seattle, WA, 98125-7001, 120 Northgate Plaza
来源
JOURNAL OF IMMUNOTHERAPY | 1997年 / 20卷 / 01期
关键词
D O I
10.1097/00002371-199701000-00001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 14
页数:14
相关论文
共 117 条
[91]  
RYSER JE, 1979, J IMMUNOL, V122, P1691
[92]   HUMAN NEOPLASMS ELICIT MULTIPLE SPECIFIC IMMUNE-RESPONSES IN THE AUTOLOGOUS HOST [J].
SAHIN, U ;
TURECI, O ;
SCHMITT, H ;
COCHLOVIUS, B ;
JOHANNES, T ;
SCHMITS, R ;
STENNER, F ;
LUO, GR ;
SCHOBERT, I ;
PFREUNDSCHUH, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) :11810-11813
[93]  
Salgaller ML, 1996, CANCER RES, V56, P4749
[94]  
SALVI S, 1995, CANCER RES, V55, P3374
[95]  
Sato T, 1996, CLIN CANCER RES, V2, P1383
[96]   HUMAN IMMUNE-RESPONSE TO DNP-MODIFIED AUTOLOGOUS CELLS AFTER TREATMENT WITH A DNP-CONJUGATED MELANOMA VACCINE [J].
SATO, T ;
MAGUIRE, HC ;
MASTRANGELO, MJ ;
BERD, D .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 74 (01) :35-43
[97]  
SCHOMBURG A, 1992, NAT IMMUN, V11, P133
[98]   IN-VITRO PREDICTORS OF THERAPEUTIC RESPONSE IN MELANOMA PATIENTS RECEIVING TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 [J].
SCHWARTZENTRUBER, DJ ;
HOM, SS ;
DADMARZ, R ;
WHITE, DE ;
YANNELLI, JR ;
STEINBERG, SM ;
ROSENBERG, SA ;
TOPALIAN, SL .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (07) :1475-1483
[99]   T-CELL RECEPTOR (TCR) STRUCTURE OF AUTOLOGOUS MELANOMA REACTIVE CYTOTOXIC T-LYMPHOCYTE (CTL) CLONES - TUMOR-INFILTRATING LYMPHOCYTES OVEREXPRESS IN-VIVO THE TCR BETA-CHAIN SEQUENCE USED BY AN HLA-A2-RESTRICTED AND MELANOCYTE-LINEAGE SPECIFIC CTL CLONE [J].
SENSI, M ;
SALVI, S ;
CASTELLI, C ;
MACCALLI, C ;
MAZZOCCHI, A ;
MORTARINI, R ;
NICOLINI, G ;
HERLYN, M ;
PARMIANI, G ;
ANICHINI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04) :1231-1246
[100]  
Slingluff CL, 1996, SEMIN SURG ONCOL, V12, P446, DOI 10.1002/(SICI)1098-2388(199611/12)12:6<446::AID-SSU10>3.0.CO